In addition, it has been proven that NAFLD severity, as assessed by liver biopsy, contributes to the increase in PAI-1 levels independent of anthropometric and metabolic parameters [99]. Here, SERPINE1 is linked to metabolic dysfunction-associated steatotic liver disease.